“…Over the past few years, we have observed an increasing trend of publications on radiomic approaches in oncology [11], especially for predicting diagnosis [12][13][14] and treatment response [15][16][17][18][19], as well as tumor molecular profiles [20,21]. In particular, in patients with HNSCC, different radiomic features extracted from computed tomography (CT) imaging, which is routinely performed in this setting, were significantly associated with clinical (local control, tumor failure, lymph node metastasis, extranodal extension, overall survival, human papillomavirus (HPV) status) and histological (differentiation grade, perineural and lymphovascular invasion) parameters as well as molecular features, especially some specific somatic mutations, in patients with head and neck cancer [22][23][24][25][26][27][28][29][30][31][32][33][34][35][36][37][38][39].…”